Lotus Pharmaceutical Co Ltd banner

Intrinsic Value

The intrinsic value of Lotus Pharmaceutical Co Ltd (1795) under the Base Case is 353.49 TWD per share. Compared with the current market price of 141.5 TWD, the stock appears Undervalued by 60% .

The intrinsic value is calculated using the DCF method. The model assumes revenue grows about 54% in 2026 and about 18% a year on average over the next five years, above its five-year pace of 14%. If revenue grew at its five-year pace of 14%, the estimate would be about NT$423.

Do our valuations actually work? See backtest results .

Intrinsic Value
NT$353.49
Undervaluation 60%
Intrinsic Value
Price NT$141.5
Alert me when Lotus Pharmaceutical Co Ltd is below its intrinsic value
Today NT$282.79 · Already reached, the price is 50.0% below it

Lotus Pharmaceutical Co Ltd is cheaper than usual. It was this cheap or cheaper on just 2% of days in the past 5 years.

Alternatives to Lotus Pharmaceutical Co Ltd

Fundamental Analysis

What Lotus Pharmaceutical Does

Pharmaceuticals Health Care

Lotus Pharmaceutical is a drug maker based in Taiwan that develops, manufactures, and sells prescription medicines, mainly generic and specialty drugs. Its portfolio includes products such as oncology treatments, hormones, and other hard-to-make medicines that are sold to hospitals, pharmacies, distributors, and healthcare partners in Asia and other export markets.

Headquarters
Taiwan TW
IPO date
Dec 13, 2004
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Lotus Pharmaceutical Co Ltd

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Continue Research

Decided on Lotus Pharmaceutical? Get an email when Lotus Pharmaceutical Co Ltd reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one Lotus Pharmaceutical Co Ltd stock?

The intrinsic value for Lotus Pharmaceutical Co Ltd (1795) under the Base Case is 353.49 TWD.

Is Lotus Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared with the current market price of 141.5 TWD, the stock appears Undervalued by 60% .

How reliable are our estimates? See how past valuations played out
Back to Top